Clinical Trial Update: Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

This document reports an update on a lisofylline trial in Type 1 diabetes, exploring continuous subcutaneous and intravenous administration in Phase 1/2. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lisofylline (lisofylline)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-08-18